These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26182957)

  • 1. Dosimetric feasibility of intensity modulated proton therapy in a transverse magnetic field of 1.5 T.
    Hartman J; Kontaxis C; Bol GH; Frank SJ; Lagendijk JJ; van Vulpen M; Raaymakers BW
    Phys Med Biol; 2015 Aug; 60(15):5955-69. PubMed ID: 26182957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
    Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
    Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Monte-Carlo study to assess the effect of 1.5 T magnetic fields on the overall robustness of pencil-beam scanning proton radiotherapy plans for prostate cancer.
    Kurz C; Landry G; Resch AF; Dedes G; Kamp F; Ganswindt U; Belka C; Raaymakers BW; Parodi K
    Phys Med Biol; 2017 Oct; 62(21):8470-8482. PubMed ID: 29047455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dosimetric comparison of intensity-modulated proton therapy optimization techniques for pediatric craniopharyngiomas: a clinical case study.
    Yeung D; McKenzie C; Indelicato DJ
    Pediatr Blood Cancer; 2014 Jan; 61(1):89-94. PubMed ID: 24000229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.
    Holliday EB; Kocak-Uzel E; Feng L; Thaker NG; Blanchard P; Rosenthal DI; Gunn GB; Garden AS; Frank SJ
    Med Dosim; 2016; 41(3):189-94. PubMed ID: 27158021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
    Rana S; Zheng Y
    J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ART for head and neck patients: On the difference between VMAT and IMPT.
    Góra J; Kuess P; Stock M; Andrzejewski P; Knäusl B; Paskeviciute B; Altorjai G; Georg D
    Acta Oncol; 2015; 54(8):1166-74. PubMed ID: 25850583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TriB-RT: Simultaneous optimization of photon, electron and proton beams.
    Kueng R; Mueller S; Loebner HA; Frei D; Volken W; Aebersold DM; Stampanoni MFM; Fix MK; Manser P
    Phys Med Biol; 2021 Feb; 66(4):045006. PubMed ID: 32413883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric feasibility of 4DCT-ventilation imaging guided proton therapy for locally advanced non-small-cell lung cancer.
    Huang Q; Jabbour SK; Xiao Z; Yue N; Wang X; Cao H; Kuang Y; Zhang Y; Nie K
    Radiat Oncol; 2018 Apr; 13(1):78. PubMed ID: 29695284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
    Koivula L; Wee L; Korhonen J
    Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can differences in linear energy transfer and thus relative biological effectiveness compromise the dosimetric advantage of intensity-modulated proton therapy as compared to passively scattered proton therapy?
    Giantsoudi D; Adams J; MacDonald S; Paganetti H
    Acta Oncol; 2018 Sep; 57(9):1259-1264. PubMed ID: 29726722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer.
    Moreno AC; Frank SJ; Garden AS; Rosenthal DI; Fuller CD; Gunn GB; Reddy JP; Morrison WH; Williamson TD; Holliday EB; Phan J; Blanchard P
    Oral Oncol; 2019 Jan; 88():66-74. PubMed ID: 30616799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rationale for intensity-modulated proton therapy in geometrically challenging cases.
    Safai S; Trofimov A; Adams JA; Engelsman M; Bortfeld T
    Phys Med Biol; 2013 Sep; 58(18):6337-53. PubMed ID: 23965339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A GPU-accelerated and Monte Carlo-based intensity modulated proton therapy optimization system.
    Ma J; Beltran C; Seum Wan Chan Tseung H; Herman MG
    Med Phys; 2014 Dec; 41(12):121707. PubMed ID: 25471954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically Applicable Monte Carlo-based Biological Dose Optimization for the Treatment of Head and Neck Cancers With Spot-Scanning Proton Therapy.
    Wan Chan Tseung HS; Ma J; Kreofsky CR; Ma DJ; Beltran C
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1535-1543. PubMed ID: 27325476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-field integrated boost treatment planning technique for spot scanning proton therapy.
    Zhu XR; Poenisch F; Li H; Zhang X; Sahoo N; Wu RY; Li X; Lee AK; Chang EL; Choi S; Pugh T; Frank SJ; Gillin MT; Mahajan A; Grosshans DR
    Radiat Oncol; 2014 Sep; 9():202. PubMed ID: 25212571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-specific bolus for range shifter air gap reduction in intensity-modulated proton therapy of head-and-neck cancer studied with Monte Carlo based plan optimization.
    Michiels S; Barragán AM; Souris K; Poels K; Crijns W; Lee JA; Sterpin E; Nuyts S; Haustermans K; Depuydt T
    Radiother Oncol; 2018 Jul; 128(1):161-166. PubMed ID: 28951008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric comparison of stopping power calibration with dual-energy CT and single-energy CT in proton therapy treatment planning.
    Zhu J; Penfold SN
    Med Phys; 2016 Jun; 43(6):2845-2854. PubMed ID: 27277033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed integer programming with dose-volume constraints in intensity-modulated proton therapy.
    Zhang P; Fan N; Shan J; Schild SE; Bues M; Liu W
    J Appl Clin Med Phys; 2017 Sep; 18(5):29-35. PubMed ID: 28681976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric feasibility of real-time MRI-guided proton therapy.
    Moteabbed M; Schuemann J; Paganetti H
    Med Phys; 2014 Nov; 41(11):111713. PubMed ID: 25370627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.